Share

Clinical Studies (3)

  • Redjoul : Study aims to evaluate vaccine immunogenicity in HSCT adult patients as a first estimation of its protective capacity in adults with such immune conditions
  • ARF-RSV : Study aims to identify and validate biomarkers associated with RSV severity in adults infected with RSV that will be useful to guide treatment decisions in the future
  • Co-SURVIVORS : Study aims to conduct a multidisciplinary assessment of respiratory, cardiac, sleep, and mental health sequelae three months after SARS-CoV-2 diagnosis in order to better characterise these complications

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • Outpatient clinic
  • Intensive care unit
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Post COVID-19 condition
  • Respiratory syncytial virus infection
  • Blood sample
  • Pharmacological intervention
  • Vaccination

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to